Adverse Overall Survival Impact of PD-L1 Positivity in Patients With KRAS G12C Mutation Is Abolished by the Immunotherapy

Clinical Lung Cancer(2021)

引用 1|浏览7
暂无评分
关键词
KRAS subtypes,Molecular profiling,Immunotherapy,PD-L1 positivity,Non–small cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要